Cryo-Cell InternationalvsEli Lilly and Company

CCEL and LLY stock compared: price, dividend, valuation and results, from SEC filings.

CCEL

Cryo-Cell International, Inc.

$4.55

Value $37M

-10.19%
CCEL's page

LLY

Eli Lilly and Company

$1,431.67

Value $1.35T

+1.14%
LLY's page

Cryo-Cell International (CCEL) has a market value of $37M and Eli Lilly and Company (LLY) $1.35T. Over the last year, with dividends, CCEL moved +19.8% and LLY +42.9%. Dividend yield: CCEL none, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CCEL$37M

    LLY$1.35T

    LLY is 36,850 times CCEL

  • Revenue, 12 months

    CCEL$31M

    LLY$86.5B

    LLY is 2,778 times CCEL

  • Net income, 12 months

    CCEL-$1.9M

    LLY$27.6B

  • Operating margin

    CCEL0.6%

    LLY–

  • ROIC

    CCEL–

    LLY35.5%

  • P/E

    CCEL–

    LLY49.0

  • Dividend yield

    CCEL0.0%

    LLY0.4%

    0.4 points apart

  • 5-year return

    CCEL-51.7%

    LLY+480.4%

    532.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CCEL-51.7%

LLY+480.4%

020040060020222023202420252026
Returns by period
PeriodCCELWith dividendsLLYWith dividends
1 year since November 12, 2025+19.8%Price +19.8%+42.9%Price +41.8%
3 years since November 13, 2023+1.2%+0.4% a yearPrice -7.6%+140.8%+34.0% a yearPrice +135.6%
5 years since November 12, 2021-51.7%-13.5% a yearPrice -60.9%+480.4%+42.2% a yearPrice +455.9%
10 years since November 16, 2016+54.5%+4.4% a yearPrice +25.0%+2,082.4%+36.1% a yearPrice +1,776.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CCELCryo-Cell InternationalLLYEli Lilly and Company

Valuation

CCELLLY
Valuation
Price$4.55$1,431.67
Market value$37M$1.35T
Enterprise value (EV)–$1.40T
P/E–49.0
P/E, 5-year median–49.9
P/B–33.5
EV/EBIT–40.1
Free cash flow yield12.7%1.5%

Results and growth

CCELLLY
Results and growth
Revenue, 12 months$31M$86.5B
Net income, 12 months-$1.9M$27.6B
Free cash flow, 12 months$4.7M$19.7B
Earnings per share, 12 months-$0.23$30.81
Revenue growth, year on year-1.3%44.7%
Revenue growth a year, past+0.3%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

CCELLLY
Margins and returns on capital
Gross margin78.5%83.6%
Operating margin0.6%–
Net margin-6.3%31.9%
ROIC–35.5%
ROE–88.6%

Balance sheet

CCELLLY
Balance sheet
Cash$4.2M$4.9B
Total debt–$49.5B
Net debt / EBITDA–1.2
Interest cover0.1×38.9×

Dividends and buybacks

CCELLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield0.5%0.3%
Shareholder yield0.5%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CCEL or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Cryo-Cell International or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.35T) is about 36,849.7 times Cryo-Cell International ($37M), at today's prices.

How did CCEL and LLY stock do over the last 10 years?

Since November 16, 2016, CCEL's price moved +25.0% and LLY's +1,776.1%. With dividends: CCEL +54.5% (+4.4% a year), LLY +2,082.4% (+36.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, CCEL or LLY?

The dividend yield at today's price is none for Cryo-Cell International and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

Which has the higher profit margins, Cryo-Cell International or Eli Lilly and Company?

Over the last twelve months, the net margin was -6.3% for Cryo-Cell International and 31.9% for Eli Lilly and Company, and the operating margin 0.6% and –. Revenue was $31M and $86.5B.

Which is the better investment, Cryo-Cell International or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.